Last reviewed · How we verify

NCT06954727: CHA-RHC

China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization

Recruiting now Last updated 21 May 2025
What this trial tests

trial testing No intervention; Observational study in Pulmonary Hypertension in 10,000 participants. Currently enrolling.

Timeline
1 January 2018
Primary endpoint
31 December 2028
31 December 2030

Quick facts

Lead sponsorChina-Japan Friendship Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment10,000
Start date1 January 2018
Primary completion31 December 2028
Estimated completion31 December 2030
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

China-Japan Friendship Hospital

Who can join

14 and older, any sex, with Pulmonary Hypertension or Pulmonary Embolism (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Right heart catheterization(RHC) plays a crucial role in the diagnosis and treatment of pulmonary vascular diseases(PVD). In China, the lack of equipment and technical expertise has historically limited the implementation of RHC, thereby greatly restricting the diagnosis and treatment of RVD. In recent years, with improvements in these issues, more hospitals have acquired the capability to perform RHC. The purpose of this study is to conduct quality control of RHC across multiple pulmonary hypertension(PH) centers in China. The study population consists of patients who underwent RHC for the first time due to dyspnea or suspected PH. This study retrospectively and prospectively collects multicenter RHC data, with the main quality control contents including indications for the procedure, collection and analysis of hemodynamic data, diagnosis and treatment, and long-term management of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention; Observational study

Trials testing the same drug.

Other recruiting trials for Pulmonary Hypertension

Currently open trials in the same condition.

Other China-Japan Friendship Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06954727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing